You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

CLINICAL TRIALS PROFILE FOR KLONOPIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for KLONOPIN

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00652639 ↗	Bioavailability Study of Clonazepam Tablets Under Fasting Conditions	Completed	Cetero Research, San Antonio	Phase 1	2004-02-01	To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg
NCT00652639 ↗	Bioavailability Study of Clonazepam Tablets Under Fasting Conditions	Completed	Par Pharmaceutical, Inc.	Phase 1	2004-02-01	To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg
NCT00652912 ↗	Bioavailability Study of Clonazepam ODT Under Fasting Conditions	Completed	Cetero Research, San Antonio	Phase 1	2004-03-01	To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
NCT00652912 ↗	Bioavailability Study of Clonazepam ODT Under Fasting Conditions	Completed	Gatway Medical Research, Inc	Phase 1	2004-03-01	To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
NCT00652912 ↗	Bioavailability Study of Clonazepam ODT Under Fasting Conditions	Completed	Par Pharmaceutical, Inc.	Phase 1	2004-03-01	To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
NCT01700829 ↗	Ketamine in the Treatment of Suicidal Depression	Completed	National Institute of Mental Health (NIMH)	Phase 4	2012-06-01	This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression. The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.
NCT01700829 ↗	Ketamine in the Treatment of Suicidal Depression	Completed	New York State Psychiatric Institute	Phase 4	2012-06-01	This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression. The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for KLONOPIN

Condition Name

Chart
Table

Condition Name for KLONOPIN
Intervention	Trials
Suicidal Ideation	2
To Determine Bioequivalence Under Fasting Conditions	2
Bipolar Disorder	1
Burning Mouth Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for KLONOPIN
Intervention	Trials
Disease	3
Depression	2
Suicidal Ideation	2
Depressive Disorder, Major	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for KLONOPIN

Trials by Country

Map
Table

Trials by Country for KLONOPIN
Location	Trials
United States	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for KLONOPIN
Location	Trials
New York	3
California	1
New Jersey	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for KLONOPIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for KLONOPIN
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	1
Phase 2	1
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for KLONOPIN
Clinical Trial Phase	Trials
Completed	5
Withdrawn	2
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KLONOPIN

Sponsor Name

Chart
Table

Sponsor Name for KLONOPIN
Sponsor	Trials
New York State Psychiatric Institute	3
Cetero Research, San Antonio	2
Par Pharmaceutical, Inc.	2
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for KLONOPIN
Sponsor	Trials
Other	12
Industry	3
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.